PMP22 expression in dermal nerve myelin from patients with CMT1A.
about
Shortened internodal length of dermal myelinated nerve fibres in Charcot-Marie-Tooth disease type 1A.The PMP22 gene and its related diseases.Polytherapy with a combination of three repurposed drugs (PXT3003) down-regulates Pmp22 over-expression and improves myelination, axonal and functional parameters in models of CMT1A neuropathy.Evaluating dermal myelinated nerve fibers in skin biopsy.Analysis of LMNB1 duplications in autosomal dominant leukodystrophy provides insights into duplication mechanisms and allele-specific expression.High-dosage ascorbic acid treatment in Charcot-Marie-Tooth disease type 1A: results of a randomized, double-masked, controlled trialInherited neuropathies: clinical overview and update.Pain in Guillain-Barré syndrome.Uses of skin biopsy for sensory and autonomic nerve assessmentAnimal models and therapeutic prospects for Charcot-Marie-Tooth disease.Towards a functional pathology of hereditary neuropathies.A rat model of Charcot-Marie-Tooth disease 1A recapitulates disease variability and supplies biomarkers of axonal loss in patients.Alternative Splicing in the Human PMP22 Gene: Implications in CMT1A Neuropathy.Caveats in the Established Understanding of CMT1A.Gene network of a phosphoglycerate mutase in muscle wasting in mice.PMP22 messenger RNA levels in skin biopsies: testing the effectiveness of a Charcot-Marie-Tooth 1A biomarker.PMP22 antisense oligonucleotides reverse Charcot-Marie-Tooth disease type 1A features in rodent models.Elevated Peripheral Myelin Protein 22, Reduced Mitotic Potential, and Proteasome Impairment in Dermal Fibroblasts from Charcot-Marie-Tooth Disease Type 1A Patients.Human amniotic fluid stem cells: neural differentiation in vitro and in vivo.Structural variations causing inherited peripheral neuropathies: A paradigm for understanding genomic organization, chromatin interactions, and gene dysregulation.Myelin and Axon Pathology in a Long-Term Study ofPMP22-Overexpressing Mice
P2860
Q33567193-6FB9C30B-F963-481E-968F-6F02B65239C4Q34316615-5C367B1A-D51A-4C57-87D0-C9308F1D380CQ34788066-3ADF9A56-1EE2-4C2D-8700-C5045443998FQ36484556-D64BA572-BD7E-4A77-A518-4BC32E77F619Q37022111-C812C8A7-996B-4C55-8DCB-880975C70505Q37118241-B15F3178-17D3-4AF1-844D-272F83E38523Q37571617-16ED61E0-C8F4-432C-95BA-95ED75BD61E3Q37849761-1346482F-EC69-4739-AEF9-98952D420C28Q38068367-0B6E5A8C-1B8D-4077-9D89-67CF5F5F0838Q38126454-6D7E67DF-3063-4736-8DE0-133B5D7DA066Q39023144-09A788FA-7994-4A64-88AF-C3A3C054A18CQ39673261-FC0EB3B8-A8B6-4F6C-959D-8D4A5166D13BQ40408847-1A27C16B-3E3C-4AC8-9A9D-AF11EC3EB752Q41357926-0FFAD0C2-7E25-4F64-B3D4-4974DD3D1674Q41491668-22AB32D8-4EF1-4AEF-83B3-B59A02B6CE14Q45222726-F74EC3AC-6A5A-4E40-9673-2EEEF309E4F3Q45875397-C5ED779F-4636-4819-8DD4-991C2B2C0C00Q47288315-47379C30-1E6D-44B6-BDB1-05E12F911DE1Q48800758-6425D393-1950-471A-981E-7E22F5173171Q55490608-60D06375-9CE3-4FCB-BF14-C975CCFFD43EQ58183071-7BFDA87E-E253-4B9C-B688-8639AD1E31DB
P2860
PMP22 expression in dermal nerve myelin from patients with CMT1A.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
PMP22 expression in dermal nerve myelin from patients with CMT1A.
@en
type
label
PMP22 expression in dermal nerve myelin from patients with CMT1A.
@en
prefLabel
PMP22 expression in dermal nerve myelin from patients with CMT1A.
@en
P2093
P2860
P356
P1433
P1476
PMP22 expression in dermal nerve myelin from patients with CMT1A
@en
P2093
Carly E Siskind
Lindsey J Miller
Shawna M E Feely
Stephanie Sottile
Xingyao Wu
P2860
P304
P356
10.1093/BRAIN/AWP113
P407
P577
2009-05-15T00:00:00Z